Navigation Links
Parents Launch SV40 Cancer Foundation In Memory of Son

Raphaele and Michael Horwin have launched the SV40 Cancer Foundation in memory of their son Alexander Horwin who died in 1999 from an SV40 positive brain tumor. // The main aim of the foundation is to "public awareness, encourage independent research and to facilitate clinical improvements."

Alexander, (http//www.ouralexander.org) died in January 1999 from a brain tumor that was caused by an active SV40 virus that contaminates both the Inactivated Polio Vaccine (IPV) of Dr Jonas Salk and the Oral or "Live" Polio Vaccine (OPV) of Dr. Albert Sabin. This conclusion was reached by doctors after extensive tests including DNA polymerase chain reaction (PCR) technology and laser micro-dissection found that Alexander's brain tumor was SV40 positive and that the virus was active. The SV 40 virus was the 40th one found in the kidney cells of Rhesus monkey when polio vaccine was made from them. It was also found that Alexander's parents did not carry the virus and that even his cord blood was negative for the same. The only remaining assumption was that the polio vaccine was contaminated and the Horowins sought legal redress by taking American Home Products to court for supplying the vaccines. But a judge found that the company was not guilty of supplying such vaccines despite evidence to the contrary. For more information visit, SV40 Cancer Foundation at http://www.SV40foundation.org
'"/>




Page: 1

Related medicine news :

1. Smoking may be influenced by Parents
2. Few Parents Help Kids Fight Acne
3. Parents Should Look For Signs Of Children Becoming Overweight
4. HIV-positive Parents Require More Counseling
5. Parents understand better the hearing loss problem in children if counseled
6. Parents Should Beware of Violent Video Games
7. Risk Of Pre-eclampsia May Be In The Genes Of The Parents.
8. Pediatricians Need To Talk To Parents Of Overweight Kids
9. Increased Monitoring By Parents May Result In Lower BMI In Children
10. Teenage Girls May Not Need Parents Consent For Abortion
11. Parents Of ADHD Children Suffering Sleep Problems
Post Your Comments:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ontrol Organization will be launching a month-long...hra Pradesh, Tamilnadu, Karnataka, Maharashtra, Ma...een HIV and TB. The campaign will be conducted thr...nt. It is pertinent to remember that the HIV virus...
...ring and Eugenics were developed by scientists wit...ry and remove all defective genes from the gene po...s are being made to order. Though it sounds absurd...tive baby?’- To some parents with disabilities lik...
...significantly cut down use of illicit drugs, but h...dangerous, say experts. // Dr. Grant Mitchell, chi...Center, in Mount Kisco, N.Y said, "This doesn't su...rescriptions for potentially legitimate uses for p...
...t that the people of India constitute more than on...e been underrepresented in studies related //to ge...on, complex genetic diseases associated with urban...ic proportions, making genetic cataloging and asso...
Other Medicine News:Health News:Can Defective Babies Be Made To Order? 2Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2
(Date:8/26/2008)... Coupled with Innovative Manufacturing - Has Poten...ic Preparedness, ROCKVILLE, Md., Aug. 26 /PRNewsw...nnounced today favorable results from the second s...s pandemic influenza virus-like,particle (VLP) vac...n an,adjuvant, induced robust neutralizing antibod...
(Date:8/25/2008)... Stem Cells Found in Menstrual Blood May Offer Lon...me-Pressed Women, OLDSMAR, Fla., Aug. 25 /PRNewsw... women would agree that there never seems to be en...pends on doing something just,for herself usually ...ers.,This reality has led many women in need of qu...
(Date:8/25/2008)...LLS, Mass., Aug. 25 /- Joseph F. Finn...Spherics, Inc. ("Spherics") for,the benefit of cre...tellectual property will be sold at a sealed bid a...ed release formulation of Levodopa-Carbidopa that,...on,s disease, with global,sales estimated at appro...
(Date:8/25/2008)...alif., Aug. 25 /- Anthera Pharmaceuti...any developing,anti-inflammatory drugs, today anno...nt Acute coronary events with Near-term Cardiovasc...gned to examine the impact of,varespladib when adm...Coronary Syndrome (ACS) event., The FRANCIS trial...
Breaking Medicine Technology:Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Mylan Announces Appointment of M Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 1305 1Mylan Announces Appointment of M Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 1305 2Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 1Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 2Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 3Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 4System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 1System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 2Common Foot Myths Trip Us Up 1298 1Common Foot Myths Trip Us Up 1298 2
... June 14, 2007) - Ambrilia,Biopharma Inc. (TSX:AMB...all molecules and peptides to treat infectious dis...ial Meeting today, during,which the data reported ...ibitors and recent developments were highlighted. ... Board, Mr. Frederic,Porte, and a progress report ...
...ewswire/ -- Results of the,Option (TOcilizumab Piv...trial, the first multinational Phase III study out...ctemra (either 4mg/kg,or 8mg/kg) plus methotrexate...mprovement in the signs and symptoms of moderate t...ients treated with,placebo and methotrexate, a cur...
Other Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit.
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box
...ntrol you've come to demand in BD K-3000 microkera...keratome is built upon. , ,The BD K-4000 Micro...e front panel on the new console has been designed...ck., ,The BD K-4000 Microkeratome has been eng...
The 4.5/5.0 mm Cannulated Screw System is part of a series of modular systems developed by DePuy ACE for cannulated screws ranging from 3.5mm to 8.0mm. Complete with instruments, disposables and scre
Medicine Products: